AI-generated summary
The authors describe a protocol for a planned randomised trial in China of intense pulsed light (IPL), 3% diquafosol eye drops, and their combination in people with evaporative dry eye, with 360 patients to be randomly assigned and followed for 4 weeks. The trial will compare tear break-up time, symptom scores, and safety outcomes across the groups. This is a study protocol, so no results are reported.
- Participants
- 360
- Who or what was studied
- Patients with evaporative dry eye disease treated at He Eye Specialist Hospital in Shenyang, China
- Limits stated in the abstract
- This is a trial protocol only, so no outcomes or findings are reported yet.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Control group, Trial registration, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.